Published in

American Society for Microbiology, Journal of Clinical Microbiology, 5(53), p. 1754-1757, 2015

DOI: 10.1128/jcm.03548-14

Links

Tools

Export citation

Search in Google Scholar

Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping

Journal article published in 2015 by 陳定信, 劉振驊, 高嘉宏, 楊宏志, 蘇東弘, 劉俊人, 陳培哲, Chen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu ORCID, Chih-Lin Lin, Tung-Hung Su ORCID, Hung-Chih Yang, Pei-Jer Chen ORCID, Ding-Shinn Chen and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

ABSTRACT Genotyping and subtyping of 225 samples with hepatitis C virus (HCV) genotype 1, 2, 3, or 6 infection were done with Versant LiPA 2.0 and Abbott RealTime HCV Genotype (GT) II by using direct sequencing of the NS5B and 5′ untranslated regions as the reference standards. The concordance rates were >99.2% for genotypes and 96.1% for subtypes 1a and 1b. Both the Abbott RealTime and Versant LiPA assays can accurately determine hepatitis C virus genotypes. (This study has been registered at ClinicalTrials.gov under registration no. NCT00979979.)